Transcatheter closure of ventricular septal defect in patients with aortic valve prolapse and mild aortic regurgitation: feasibility and preliminary outcome

Guan-Liang Chen, Haitao Li, Hairong Li, Zhiwei ZhangAsian 2015 · DOI

TL;DR

This paper investigates the feasibility and preliminary outcomes of transcatheter closure for ventricular septal defects (VSDs) in patients who also have aortic valve prolapse (AVP) and mild aortic regurgitation (AR). The study demonstrates that this minimally invasive approach is technically feasible and highly effective, offering a promising alternative to surgery for this specific patient subset.

What Problem Does This Paper Address?

Ventricular septal defects (VSDs) are common congenital heart conditions. While transcatheter closure has become a well-established alternative to surgical repair, its application in patients with co-existing aortic valve prolapse (AVP) and mild aortic regurgitation (AR) presents a unique challenge. The concern is that the presence of AVP and AR might be exacerbated by the device used for VSD closure, potentially leading to more severe regurgitation and adverse hemodynamic consequences. Existing literature on this specific patient subgroup is limited, making it difficult to assess the safety and efficacy of transcatheter VSD closure in these cases. This paper aims to fill that gap by evaluating the procedure's feasibility, safety, and preliminary outcomes in a cohort of patients with VSD, AVP, and mild AR.

Methods

The study employed a retrospective analysis of 65 patients who underwent transcatheter closure of VSD between January 2008 and July 2014. The primary device used was the HeartRT™ VSD Occluder, a self-expandable, double-disc device made of Nitinol wire mesh. The selection of the device size was crucial, typically chosen to be 1-2 mm larger than the measured VSD diameter, with a potential for using a 2-4 mm larger device if initial closure was insufficient or the device dislodged.

Pre-procedural evaluation involved transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) to assess VSD diameter, rim integrity, and the severity of AVP and AR. Patients with infective endocarditis, sepsis, complex heart lesions requiring surgery, or contraindications to antiplatelet therapy were excluded.

The implantation procedure involved standard cardiac catheterization techniques, including right and left heart catheterization and left ventricular angiography. Access was gained via the femoral artery and vein. Heparin and antibiotics were administered prophylactically. Procedures for children under 10 years were performed under general anesthesia, while older patients received local anesthesia. Post-procedure, patients were administered oral aspirin.

Complications were categorized as severe (death, embolism, device dislocation, persistent AV block requiring pacing), moderate (significant device-related AR, worsened cardiac dysfunction requiring drug treatment), or mild (peripheral hemorrhage, transient complete left bundle branch block, transient third-degree AV block).

Follow-up included clinical examinations, echocardiography, chest radiography, and electrocardiography at regular intervals (1, 3, 6, and 12 months post-procedure).

Datasets

Not discussed in the paper. The study utilized patient data collected during clinical procedures and follow-up assessments.

Key Insights and Ideas

  • Feasibility in a Challenging Subset: The study demonstrates that transcatheter closure of VSD is not only feasible but also highly effective in patients with co-existing AVP and mild AR, a group previously considered more challenging.
  • Potential for AR Improvement: Surprisingly, the procedure not only closed the VSD but also led to an amelioration of both aortic regurgitation (AR) and aortic valve prolapse (AVP) in a significant proportion of patients at one-year follow-up. This suggests that the device might offer some beneficial support to the aortic valve leaflets.
  • Device Support Mechanism: The authors hypothesize that the occluder might provide commissural support to the prolapsed aortic valve leaflets, potentially preventing further deterioration of AR and improving the overall hemodynamic configuration.
  • Importance of Pre-operative Assessment: The study underscores the critical role of meticulous pre-operative evaluation of anatomical and pathophysiological characteristics to ensure proper patient selection and avoid unnecessary attempts.

Key Results

  • High Success Rate: The overall immediate success rate for device placement was 96.9% (56 out of 65 patients at the first attempt, with 7 requiring re-intervention due to inappropriate device size). Two patients discontinued the procedure due to significant aggravation of device-related AR.
  • Low Complication Rate: A total of 7 complications (10.8%) were reported in 65 patients. There were no deaths, major bleeding, pericardial tamponade, occluder dislodgement, residual shunts, or hemolysis.
  • Moderate complications occurred in 2 patients (3.0%) due to significant device-related AR.
  • Mild complications occurred in 5 patients (7.7%), including peripheral hemorrhage and transient atrioventricular block.
  • Long-Term Outcomes (1-year follow-up for 63 patients):
    • No residual shunts were detected.
  • AR severity was relieved in 61.9% (39/63) of cases.
  • AVP severity was ameliorated in 36.5% (23/63) of cases.

Limitations and Future Work

  • Limited Sample Size for AVP/AR Subset: While 65 patients underwent the procedure, the specific subset with AVP and mild AR is a significant portion, but the authors acknowledge that long-term safety and efficacy need further assessment.
  • Underestimation of AVP Movement: The authors note that conventional left ventricular angiography and TTE might sometimes underestimate the movement of prolapsed aortic valves. They suggest that intraoperative angulation projections and alternative TTE views could improve anatomical and functional assessment.
  • Subaortic Rim Requirement: The study implies that a subaortic rim of at least 3 mm is important for successful closure, as two unsuccessful percutaneous attempts occurred in patients with potentially inadequate rims.
  • Future Work: The authors emphasize the need for long-term follow-up to fully assess the safety and efficacy of this procedure in patients with AVP and mild AR. Further research could explore the precise mechanisms by which the device might improve AR and AVP, and refine patient selection criteria.

Summary updated

Abstract

Transcatheter closure VSD in selected patients with AVP and mild AR is technically feasible and highly effective. Long term safety and efficacy needs to be assessed.
BibTeX
@inproceedings{chen2015transcatheter,
  author = {Guan-Liang Chen and Haitao Li and Hairong Li and Zhiwei Zhang},
  title = {{Transcatheter closure of ventricular septal defect in patients with aortic valve prolapse and mild aortic regurgitation: feasibility and preliminary outcome}},
  booktitle = {Asian},
  year = {2015},
  doi = {10.1016/s1995-7645(14)60337-0},
}
Figure